TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. - Wikidata - wikimedia - TriplyDB

TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

http://www.wikidata.org/entity/Q35085542

about

Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer Progression Circulating cancer stem cells: the importance to select From sprouting angiogenesis to erythrocytes generation by cancer stem cells: evolving concepts in tumor microcirculation Metastatic cancer stem cells: from the concept to therapeutics Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneity Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention Transforming growth factor β as regulator of cancer stemness and metastasis TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Cancer stem cells and tumor metastasis (Review).Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis.Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.Obesity and cancer--mechanisms underlying tumour progression and recurrence Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.An integrated expression profiling reveals target genes of TGF-β and TNF-α possibly mediated by microRNAs in lung cancer cells Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells Epithelial-mesenchymal transition in keratocystic odontogenic tumor: possible role in locally aggressive behavior.Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells BTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila.Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.Understanding cancer stem cell heterogeneity and plasticity.CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.Epithelial cell culture models for the prevention and therapy of clinical breast cancer (Review).Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

P2860

Q21245487-C3124E23-C228-4AA4-BD08-E97AEBC1D6DC Q26744536-9A5DF56A-7AFF-4CB8-A135-0A28F529E3F4 Q26768428-308E9994-5E2F-4E95-85D6-00429B3316E1 Q26778924-A6B1D7CC-CBDC-47C7-85A8-8221A1D4E2AE Q26827148-BAB2E346-23C9-42F1-9EFB-E805F0AF7A4B Q26850739-90551336-1038-4C27-9740-5F4EBCA52DDE Q26851620-9B522831-3800-4FE9-AF81-85E8A69018EC Q26852215-D4B4FA1F-F9B9-42F8-A28D-D0A7DF1798B0 Q27340972-A1C3D8C3-62CF-434D-881D-AF69C7CE96AA Q28066409-0C78DAAA-C0EA-4709-AF6F-6CF49500762F Q28069232-B2ABC15F-D808-4235-80A8-208263B2CE75 Q28077319-E86E80F5-4087-483A-B2DC-1413E0611286 Q28248954-89F14CBE-B647-4DC3-8D8E-751D569951D9 Q28393898-05A0DCB2-2C8E-45C3-BAF3-36D1FAA8FDC6 Q28543036-EBC96DEE-3DFA-4062-B2C7-2D2D692A4D6D Q30301260-11E6CCE6-0C0F-4437-863D-4E413B5E0265 Q30833237-2A6EDA39-16FA-42F6-981B-A76515B996AA Q33710602-86F94743-BFC7-4AB0-BB2E-EB04FBFF06CC Q33737278-8D7BB791-37E5-49AE-86D8-10BEE9CB6CCC Q33778124-7D328C67-533B-49DE-ACA4-06022CC74C8E Q33875120-72B5F3E4-8831-4750-9E44-716DBFCC956B Q33892569-515B3E20-68BF-47F9-84FA-16C27BF1DA4D Q34249060-D7D08F85-1386-4D54-B12D-0E27BF748913 Q34271512-F500913B-7CA7-4C81-8A98-5C8FBBCBF0EF Q34288822-D653AF26-67AA-4C17-AF80-EAA92BA4F4DA Q34425077-EA552E00-6191-4053-BDBE-2CB31CC1A4A9 Q34571496-ED75C53F-EF6F-41DD-8A37-D7793FAEB67D Q34599038-7FE1E512-F046-446E-99EE-C8BD0D2AF439 Q34677454-37D93157-4330-4691-9000-FE2EB8FB1BF3 Q35067924-E4EE5140-67B9-4B68-8BD2-90F55226479E Q35080755-233BF56A-4B00-4CF8-8BC3-159A5BF91C20 Q35281849-574C83C6-3CFC-493B-BCEA-056AA4BBA01E Q35710589-B89E71B5-049D-48B7-BF44-6BB3FA97177E Q35711047-C4F72491-21FC-49A4-A592-54E679CAB6E4 Q35762816-65D7684A-D585-43C2-8C1E-D83686A2ED8A Q35796886-68A5E0B7-E7EE-44BB-AC34-B0D5E11B52EB Q35941297-312AC92E-A94C-42AE-81E6-37980B0A030A Q35995983-2861191F-1B69-46DB-8A93-C3379A8614A1 Q36015463-4E525CE7-79C0-425B-9055-ADBB7B3F4A88 Q36040355-C915793F-74F9-4679-87FF-9442C0E6A77D

P2860

TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

http://www.wikidata.org/entity/Q35085542

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.

@ast

TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.

@en

type

label

TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.

@ast

TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.

@en

prefLabel

TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.

@ast

TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.

@en

P1433

Q35085542-B446FE89-BE30-4B5F-AF79-83BE063EA56D

P1476

Q35085542-40C2F567-33EB-4031-9A09-2EA5F7B01294

P2093

Q35085542-1CF9B691-8D53-4930-ACA5-E2CCB5E13E7C

Q35085542-53F43083-DBD5-4337-BA0B-28B1A45EB60C

Q35085542-56A12F34-E614-4A3F-AE69-15CB90AE8CD0

Q35085542-68254E1B-B7E8-4DC7-B14E-CD94E497A07C

Q35085542-9EBE0B4D-2493-4EA0-9719-608CC1D27CA6

P2860

Q35085542-01046C84-45E9-4E07-A7F2-4D29FE2F47D5

Q35085542-05ADC4B8-FA81-4BEB-88AB-682E2BAD213F

Q35085542-08F3952F-616B-49CC-8739-0DEE290CFE06

Q35085542-09DA8C68-4DC7-4F73-88A9-0831F2839AF2

Q35085542-1F8C699E-4146-444F-AE7B-439F7AC3D3BE

Q35085542-28597C91-2747-4335-A2D5-055CCD3541A0

Q35085542-2B4F9AD1-6A82-4BC0-B093-FC392DF5FE01

Q35085542-34AD899F-B402-425E-85FB-A4A68191D309

Q35085542-420B3F6A-9365-4DDC-9422-864A6144D820

Q35085542-451DBCF3-AEA7-404D-B67B-9A490B72FA0F

P304

Q35085542-9C671715-3974-4954-81E4-FCF054569D8A

P31

Q35085542-CD322F20-E9D4-41C4-A2AC-70E6F9A062D2

P356

Q35085542-BA3BA226-2C71-43EF-8A26-77EEC11E3DDE

P407

Q35085542-4A5DDF2D-0A21-4CC4-B978-C0D89CA92F59

P433

Q35085542-A029C887-8BBA-4D88-B51D-0F7D62CBF41E

P478

Q35085542-94EDA7AA-092E-4D03-886B-3A42FBEB0AB0

P577

Q35085542-52005749-30FF-49B1-BD15-18622BE6C92E

P698

Q35085542-F9436A27-7180-4952-85CE-7704DF7EE7EA

P921

Q35085542-A94E3541-CAF4-4D12-9181-9B19B0DB6E75

P932

Q35085542-F129A0DA-C43F-44B6-8AD1-882486C1BF15

P356

0008-5472.CAN-10-4554

P1433

Cancer Research

P1476

TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.

@en

P2093

Derek C Radisky

http://www.w3.org/2001/XMLSchema#string

James N Ingle

http://www.w3.org/2001/XMLSchema#string

Keith L Knutson

http://www.w3.org/2001/XMLSchema#string

Marshall D Behrens

http://www.w3.org/2001/XMLSchema#string

Michael K Asiedu

http://www.w3.org/2001/XMLSchema#string

P2860

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

The epithelial-mesenchymal transition generates cells with properties of stem cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

Epithelial-mesenchymal transitions in development and disease

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

TGFbeta signaling in growth control, cancer, and heritable disorders

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

Identification of selective inhibitors of cancer stem cells by high-throughput screening

P304

4707-4719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-4554

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21555371

http://www.w3.org/2001/XMLSchema#string

P921

P932

3129359

http://www.w3.org/2001/XMLSchema#string